197 related articles for article (PubMed ID: 16497638)
1. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
Wasilewska A; Zoch-Zwierz W; Tenderenda E
Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
[TBL] [Abstract][Full Text] [Related]
2. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome.
Wasilewska A; Zoch-Zwierz W
Acta Paediatr; 2006 May; 95(5):587-93. PubMed ID: 16825140
[TBL] [Abstract][Full Text] [Related]
4. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Hoyer PF; Brodeh J
J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[TBL] [Abstract][Full Text] [Related]
6. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
Tkaczyk M; Owczarek D; Finke D; Nowicki M
Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
[TBL] [Abstract][Full Text] [Related]
7. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.
Wasilewska A; Zoch-Zwierz W; Pietruczuk M
Eur J Pediatr; 2007 May; 166(5):447-52. PubMed ID: 17024347
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment].
Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Wierciński R; Winiecka W; Smółko M; Porowski T; Koput A; Janicka K
Pol Merkur Lekarski; 2003 Aug; 15(86):172-5. PubMed ID: 14648986
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 in nephrotic syndrome treated with cyclosporine and ACE inhibitors.
Wasilewska AM; Zoch-Zwierz WM
Pediatr Nephrol; 2004 Dec; 19(12):1349-53. PubMed ID: 15490252
[TBL] [Abstract][Full Text] [Related]
11. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria.
Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K; Kołodziejczyk Z
Scand J Urol Nephrol; 2011 Feb; 45(1):52-9. PubMed ID: 21034351
[TBL] [Abstract][Full Text] [Related]
12. [Plasma concentrations of vascular endothelial growth factor and tissue factor in children with acute lymphoblastic leukemia].
Yang HQ; Zhang RH; Zhang ZH; Wan CC; Xia YJ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):526-8. PubMed ID: 18082030
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine experience in nephrotic syndrome.
Phadke K; Ballal S; Maiya V
Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
[TBL] [Abstract][Full Text] [Related]
14. High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.
Wasilewska A; Zoch-Zwierz W; Tobolczyk J; Tenderenda E
Pediatr Nephrol; 2007 Mar; 22(3):403-8. PubMed ID: 17115196
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
[TBL] [Abstract][Full Text] [Related]
17. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome.
Cheong HI; Lee JH; Hahn H; Park HW; Ha IS; Choi Y
J Nephrol; 2001; 14(4):263-9. PubMed ID: 11506248
[TBL] [Abstract][Full Text] [Related]
18. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
[TBL] [Abstract][Full Text] [Related]
19. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Eguchi A; Takei T; Yoshida T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):124-9. PubMed ID: 19740915
[TBL] [Abstract][Full Text] [Related]
20. [Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome].
Tenderenda E; Korzeniecka-Kozerska A; Porowski T; Wasilewska A; Zoch-Zwierz W
Pol Merkur Lekarski; 2011 Oct; 31(184):204-8. PubMed ID: 22097175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
